Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000252825 | SCV000309199 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000680322 | SCV000516291 | likely benign | not provided | 2016-09-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001410326 | SCV001612371 | likely benign | RASopathy | 2024-09-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002500898 | SCV002808375 | likely benign | Noonan syndrome 1; Juvenile myelomonocytic leukemia; Metachondromatosis; LEOPARD syndrome 1 | 2021-10-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003362737 | SCV004080310 | likely benign | Cardiovascular phenotype | 2023-06-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |